These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
608 related articles for article (PubMed ID: 21749383)
1. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383 [TBL] [Abstract][Full Text] [Related]
2. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model. Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583 [TBL] [Abstract][Full Text] [Related]
3. The effect of treatment with a sustained-release prostacyclin analogue (ONO-1301-loaded PLGA microsphere) on short-term memory impairment in rats with transient global cerebral ischemia. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T J Microencapsul; 2012; 29(3):211-8. PubMed ID: 22360765 [TBL] [Abstract][Full Text] [Related]
4. Single injection of ONO-1301-loaded PLGA microspheres directly after ischaemia reduces ischaemic damage in rats subjected to middle cerebral artery occlusion. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Uchida T J Pharm Pharmacol; 2012 Mar; 64(3):353-9. PubMed ID: 22309267 [TBL] [Abstract][Full Text] [Related]
5. Effect of antioxidants on the stability of ONO-1301, a novel long-acting prostacyclin agonist, loaded in PLGA microspheres. Uchida T; Hazekawa M; Morisaki T; Yoshida M; Sakai Y J Microencapsul; 2013; 30(3):245-56. PubMed ID: 23094609 [TBL] [Abstract][Full Text] [Related]
6. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Janoria KG; Mitra AK Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats. Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
9. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
10. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere. Park W; Kim D; Kang HC; Bae YH; Na K Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184 [TBL] [Abstract][Full Text] [Related]
11. Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats. Obata H; Sakai Y; Ohnishi S; Takeshita S; Mori H; Kodama M; Kangawa K; Aizawa Y; Nagaya N Am J Respir Crit Care Med; 2008 Jan; 177(2):195-201. PubMed ID: 17975203 [TBL] [Abstract][Full Text] [Related]
12. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Doan TV; Olivier JC Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Jiang G; Qiu W; DeLuca PP Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968 [TBL] [Abstract][Full Text] [Related]
15. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
16. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
17. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761 [TBL] [Abstract][Full Text] [Related]
18. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study. Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053 [TBL] [Abstract][Full Text] [Related]
19. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres. Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717 [TBL] [Abstract][Full Text] [Related]
20. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies. Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]